(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SECARNA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SECARNA

ST13

US500000079340689

Class

42, 45

Filing

79340689

Registration

7220464

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

03/18/2024

Trademark type

Word

Nice classes

42, 45

Filing date

01/19/2022

Registration date

11/21/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/21/2023

Last transaction

11/21/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

28

Owner location

DE

Examiner

HAYS, CANDACE

Law office

M10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Secarna Pharmaceuticals GmbH & Co. KG

Representatives

B. Anna McCoy McCoy Russell LLP

Technical classification

Nice Classes

Class 42Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Scientific research services in the field of biochemistryexcept for the field of cell culture products; Scientific research services in the field of nucleic acids and bioinformaticsin particular molecular- biological work methodsespecially antisense technology; design of pharmaceutical active ingredients by means of the aforesaid methods and technologiesalso using techniques of bioinformatics; development of pharmaceutical products by means of the aforesaid methods and technologiesalso using techniques of bioinformaticsincluding carrying out associated test and diagnostic methods; information technology (IT) consultancy services for the pharmaceutical and biotechnological industry; consultancy for others in the field of biochemistry and nucleic acids and bioinformaticsincluding antisense technologywith respect to the development of pharmaceutical products; safety and efficacy testing consultancy for others with respect to the evaluation of safety and efficacy of pharmaceutics; evaluation of pharmaceutical products with respect to their safety and efficacy to assure compliance with industry standards

Class 45

Granting of licenses to others in industrial property rights in the field of scientific research services in the field of biochemistryexcept for the field of cell culture productsscientific research services in the field of nucleic acids and bioinformaticsin particular molecular-biological work methodsespecially antisense technologydesign of pharmaceutical active ingredients by means of the aforesaid methods and technologiesalso using techniques of bioinformatics and development of pharmaceutical products by means of the aforesaid methods and technologiesalso using techniques of bioinformaticsincluding carrying out associated test and diagnostic methods

Publications

History of USPTO decisions and trademark events.

34 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/18/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/22/2024

FIMP

FINAL DISPOSITION PROCESSED

02/22/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/21/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/21/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

11/21/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

11/12/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/25/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

10/25/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/05/2023

PUBO

PUBLISHED FOR OPPOSITION

09/05/2023

GPNX

NOTIFICATION PROCESSED BY IB

09/04/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/16/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/16/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/16/2023

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

07/25/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/10/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

06/14/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/14/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

06/14/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/14/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/09/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/08/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/08/2023

RFNT

REFUSAL PROCESSED BY IB

02/07/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/17/2023

RFRR

REFUSAL PROCESSED BY MPU

01/17/2023

DOCK

ASSIGNED TO EXAMINER

01/17/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/07/2022

CNRT

NON-FINAL ACTION WRITTEN

11/06/2022

DOCK

ASSIGNED TO EXAMINER

10/28/2022

MAFR

APPLICATION FILING RECEIPT MAILED

05/24/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/20/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/19/2022

Continuous trademark protection

Get notified about every new filing that threatens SECARNA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.